Learn More
BACKGROUND Combination therapy with ezetimibe/simvastatin (E/S) and extended-release niacin (N) has been reported to be safe and efficacious in concomitantly reducing low-density lipoprotein(More)
BACKGROUND Recent trends suggest a decreased use of ezetimibe/simvastatin combination and coadministered ezetimibe plus statin therapies. OBJECTIVE This analysis evaluated changes in prescription(More)